Coverage skews heavily toward the biggest companies: 43 percent of firms with 5,000 or more workers covered them, up from 28 percent the year before, while 30 percent of mid-sized firms with 1,000 to 4,999 workers did, up from 24 percent
NAD+ is undergoing clinical trials for several aging-related indications
Caprara C, Virz GM, Chieregato K, Marchionna N, Corradi V, Brendolan A, et al
GLUTATHIONE L G
Cagrilintide + Tirzepatide Storage & Handling Storage Reference (Both Compounds) State Lyophilized (long-term) Tirzepatide -4 F (-20 C), 12+ months Cagrilintide -4 F (-20 C), 12+ months State Lyophilized (short-term) Tirzepatide 35.6-46.4 F (2-8 C), several months Cagrilintide 35.6-46.4 F (2-8 C), several months State Reconstituted (liquid) Tirzepatide 35.6-46.4 F (2-8 C), 28-30 days Cagrilintide 35.6-46.4 F (2-8 C), 28-30 days State Color when reconstituted Tirzepatide Clear, colorless Cagrilintide Clear, colorless State Shake